GlassScriptPhysician profile
Susan E Gripp
NPI 1679156541
$1,167.21
in general payments reported to CMS, 2019-2025
15 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $250 · 2023: $171 · 2024: $411 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.47 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $216.40 | 2021-2025 | Qelbree, Qelbree |
| Axsome Therapeutics, INC. | $96.94 | 2023-2025 | Auvelity |
| Tris Pharma INC | $89.66 | 2023-2025 | Dyanavel Xr |
| Neos Therapeutics, LP | $70.34 | 2024 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Corium, LLC | $68.01 | 2023-2025 | Azstarys |
| Noven Therapeutics, LLC | $46.29 | 2024-2025 | Xelstrym, Secuado |
| Ironshore Pharmaceuticals INC. | $45.99 | 2021-2024 | |
| Idorsia Pharmaceuticals US INC | $36.24 | 2025 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $28.93 | 2021-2024 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.81 | 2024 | Caplyta |
| Bausch Health US, LLC | $18.26 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.64 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $17.07 | 2025 | Rexulti |
| Jazz Pharmaceuticals INC. | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Gripp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.